Skip to content

Advertisement

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Melanoma cells replicate through chemotherapy by reducing levels of key homologous recombination protein RAD51 and increasing expression of translesion synthesis DNA polymerase ζ

  • Liang Song1,
  • Ewan M. McNeil1,
  • Ann-Marie Ritchie1,
  • Katy R. Astell1, 2,
  • Charlie Gourley1 and
  • David W. Melton1Email author
BMC Cancer201717:864

https://doi.org/10.1186/s12885-017-3864-6

Received: 30 March 2017

Accepted: 30 November 2017

Published: 18 December 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
30 Mar 2017 Submitted Original manuscript
16 Jul 2017 Reviewed Reviewer Report - Brian Gabrielli
15 Aug 2017 Reviewed Reviewer Report - Bernd Kaina
18 Aug 2017 Reviewed Reviewer Report - Michael Carty
27 Sep 2017 Author responded Author comments - Liang Song
Resubmission - Version 2
27 Sep 2017 Submitted Manuscript version 2
5 Oct 2017 Reviewed Reviewer Report - Bernd Kaina
11 Oct 2017 Reviewed Reviewer Report - Brian Gabrielli
28 Nov 2017 Author responded Author comments - Liang Song
Resubmission - Version 3
28 Nov 2017 Submitted Manuscript version 3
Publishing
30 Nov 2017 Editorially accepted
18 Dec 2017 Article published 10.1186/s12885-017-3864-6

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Edinburgh Cancer Research Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK
(2)
Present Address: Centre for Neuroregeneration, University of Edinburgh, Edinburgh, UK

Advertisement